nialamide has been researched along with Chronic Disease in 3 studies
Nialamide: An MAO inhibitor that is used as an antidepressive agent.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| SMITH, JA | 1 |
| Subrahmanyam, S | 1 |
| Morozov, LT | 1 |
3 other studies available for nialamide and Chronic Disease
| Article | Year |
|---|---|
A trial of nialamide in chronically ill mental patients.
Topics: Chronic Disease; Electroconvulsive Therapy; Humans; Isoniazid; Mental Disorders; Mentally Ill Person | 1959 |
Role of biogenic amines in certain pathological conditions.
Topics: Acute Disease; Adult; Aggression; Biogenic Amines; Bipolar Disorder; Chlorpromazine; Chronic Disease | 1975 |
[Toxicity of a dimethoxyphenylethylamine incubate with the blood plasma of schizophrenia patients].
Topics: Acute Disease; Animals; Chronic Disease; Dimethoxyphenylethylamine; Humans; Iproniazid; Mice; Nialam | 1974 |